Conversely, in tumours of patients with T-cell lymphomas and diffuse large B-cell lymphoma (DLBCL), CD30 expression is more variable (Bossard et al, 2014; Slack et al, 2014; Jacobsen et al, 2015). This evidence concerns the gene TNFRSF8 and neoplasm.